RT Book, Section
A1 Gupta, Rohit R.
A1 Aldeguer, Ylaine Rose T.
A2 Oropello, John M.
A2 Pastores, Stephen M.
A2 Kvetan, Vladimir
SR Print(0)
ID 1136419333
T1 Cardioversion and Defibrillation
T2 Critical Care
YR 1
FD 1
PB McGraw-Hill Education
PP New York, NY
SN 9780071820813
LK accessmedicine.mhmedical.com/content.aspx?aid=1136419333
RD 2024/04/23
AB KEY  POINTSBiphasic  waveform  cardioversion  is  safe  and  equally  effective  as  monophasic  cardioversion,  using  much  lower  energy  with  reduced  post-shock  complications  such  as  cardiac  dysfunction,  dysrhythmias,  and  skin  burns.Defibrillation  or  unsynchronized  cardioversion  is  indicated  in  any  patient  with  pulseless  VT/VF  or  unstable  polymorphic  VT,  where  synchronized  cardioversion  is  not  possible.Synchronized  cardioversion  is  utilized  for  the  treatment  of  persistent  unstable  tachyarrhythmia  in  patients  without  loss  of  pulse.  Amongst  this  category,  AF  remains  the  most  frequently  encountered.In  critically  ill  patients,  unstable  supraventricular  tachyarrhythmias  benefit  from  individualized  therapy  such  as  inotrope  and  vasopressor  support,  antiarrhythmic  medications  or  mechanical  ventilation  and  not  necessarily  electrical  cardioversion  as  the  first  treatment.It  is  important  to  become  familiar  with  the  cardioversion  device  available,  the  appropriate  energy  settings  and  the  correct  placement  of  the  paddles  to  ensure  effective  and  timely  shock  administration.